MENU
EQ
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Equillium (EQ) Earnings Date & Reports

Equillium Inc is a clinical-stage biotechnology company engaged in developing novel therapeutics to treat severe autoimmune and inflammatory, or immuno-inflammatory, disorders with high unmet medical need... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

EQ is expected to report earnings to rise 16.67% to -7 cents per share on March 26

Equillium EQ Stock Earnings Reports
Q4'25
Est.
$-0.07
Q3'25
Beat
by $0.16
Q2'25
Beat
by $0.03
Q1'25
Missed
by $0.12
Q4'24
Beat
by $0.15
The last earnings report on November 13 showed earnings per share of -5 cents, beating the estimate of -21 cents. With 113.54K shares outstanding, the current market capitalization sits at 60.89M.
View a ticker or compare two or three
EQ
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. EQ showed earnings on November 13, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a developer of products for severe immune-inflammatory disorders

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
2223 Avenida De La Playa
Phone
+1 858 240-1200
Employees
44
Web
https://www.equilliumbio.com